Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Clinical trial NCT00190892 · COMPLETED

Trial details

NCT number: NCT00190892
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2004-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.